Danapha Pharmaceutical JSC (HSTC:DAN) Other Financing: ₫0.00 Mil (TTM As of . 20)


HSTC:DAN Danapha Pharmaceutical JSC HSTC:DAN
31 GF Score
Price ₫30,300.00
! 1 Warning Sign
View Full Analysis

What is Danapha Pharmaceutical JSC Other Financing?

Danapha Pharmaceutical JSC HSTC:DAN 31 Other Financing is ₫0.00 Mil as of . 20. GuruFocus rates HSTC:DAN with a GF Score™ of 31/100. The stock has 1 warning sign investors should review.

Danapha Pharmaceutical JSC's Other Financing for the six months ended in . 20 was ₫0.00 Mil.

Danapha Pharmaceutical JSC's Other Financing for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

Danapha Pharmaceutical JSC Other Financing Historical Data

* Premium members only.

The historical data trend for Danapha Pharmaceutical JSC's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danapha Pharmaceutical JSC Other Financing Chart

Danapha Pharmaceutical JSC Annual Data
Trend
Other Financing

Danapha Pharmaceutical JSC Semi-Annual Data
Other Financing
HSTC:DAN
31GF Score
Danapha Pharmaceutical JSC HSTC:DAN
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Danapha Pharmaceutical JSC Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Financing for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ₫0.00 Mil mean?
Danapha Pharmaceutical JSC (HSTC:DAN) has a Other Financing of ₫0.00 Mil as of . 20. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Danapha Pharmaceutical JSC and its competitors.
Is Danapha Pharmaceutical JSC's Other Financing too high?
Danapha Pharmaceutical JSC's current Other Financing is ₫0.00 Mil. Overall, Danapha Pharmaceutical JSC has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Danapha Pharmaceutical JSC's Other Financing compare to ZTS and UTHR?
Danapha Pharmaceutical JSC's Other Financing of ₫0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Danapha Pharmaceutical JSC and its competitors. Danapha Pharmaceutical JSC's current Other Financing is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Danapha Pharmaceutical JSC stock overvalued right now?
Danapha Pharmaceutical JSC (HSTC:DAN) has a current Other Financing of ₫0.00 Mil. The current Other Financing is ₫0.00 Mil. Danapha Pharmaceutical JSC's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Danapha Pharmaceutical JSC (HSTC:DAN), the current Other Financing is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Danapha Pharmaceutical JSC Business Description

Address 253 Dung Si Thanh Khe, Da Nang, VNM
Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.
31GF Score

Get the complete analysis for HSTC:DAN

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫30,300.00
Price